Showing 1 – 20 of 6589
Relevance | Newest | Oldest |
  • Science and the Trump Administration

    Abstract Full Text
    free access
    JAMA. 2017; 318(14):1312-1313. doi: 10.1001/jama.2017.14813
  • The Economics of Medicaid Reform and Block Grants

    Abstract Full Text
    free access
    JAMA. 2017; 317(10):1007-1008. doi: 10.1001/jama.2017.0901
  • Antimicrobial Resistance

    Abstract Full Text
    is active quiz
    JAMA. 2016; 316(11):1193-1204. doi: 10.1001/jama.2016.11764

    In this Special Communication, Anthony Fauci and colleagues review ecological factors contributing to, mechanisms of, and novel strategies to manage antimicrobial resistance.

  • JAMA August 2, 2016

    Figure 1: Percentage of Individuals in the United States Without Health Insurance, 1963-2015

    Data are derived from the National Health Interview Survey and, for years prior to 1982, supplementary information from other survey sources and administrative records. The methods used to construct a comparable series spanning the entire period build on those in Cohen et al and Cohen and are described in detail in Council of Economic Advisers 2014. For years 1989 and later, data are annual. For prior years, data are generally but not always biannual. ACA indicates Affordable Care Act.
  • Neglected Dimensions of Global Security: The Global Health Risk Framework Commission

    Abstract Full Text
    JAMA. 2016; 315(14):1451-1452. doi: 10.1001/jama.2016.1964

    This Viewpoint discusses the Global Health Risk Framework Commission’s strategy to safeguard human and economic security from pandemic threats.

  • The Transformation of US Physicians

    Abstract Full Text
    JAMA. 2015; 313(18):1821-1822. doi: 10.1001/jama.2015.2915

    This Viewpoint discusses challenges faced by US physicians as a result of major changes in medical practice.

  • Cost-effectiveness of Dalteparin vs Unfractionated Heparin for the Prevention of Venous Thromboembolism in Critically Ill Patients

    Abstract Full Text
    free access
    JAMA. 2014; 312(20):2135-2145. doi: 10.1001/jama.2014.15101

    This prospective economic evaluation reports that use of LMW heparin for venous thromboembolism prophylaxis in critically ill patients was more effective than unfractionated heparin, with similar or lower costs.

  • JAMA November 26, 2014

    Figure: Average Life Expectancy vs Health Care Expenditures

    The data points are health care expenditures as a percentage of gross domestic product (GDP) in 2009 for Organization for Economic Co-operation and Development (OECD) countries and higher- and lower-income US states. The GDP for each US state was calculated by dividing the US state’s health care expenditures as a percentage of the US state’s personal income by 1.16, which is the US ratio of GDP to personal income. Using personal income as the base preserves more accurately the variation across US states in economic well-being. Adjusting the level by the ratio of GDP to personal income makes the US state data more comparable with the OECD data. The OECD countries with at least $2400 per capita in health care expenditures are Australia, Austria, Belgium, Canada, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Japan, Korea, Luxembourg, the Netherlands, New Zealand, Norway, Portugal, Slovenia, Spain, Sweden, Switzerland, and the United Kingdom. The diagonal line indicates the linear relationship between life expectancy and health care expenditures as a percentage of GDP as calculated by a linear regression fitted to the 25 observations for the low-income US states.
  • Critiquing US Health Care

    Abstract Full Text
    JAMA. 2014; 312(20):2095-2096. doi: 10.1001/jama.2014.14114

    This Viewpoint discusses the economics of the US health care system.

  • Reshaping US Health Care: From Competition and Confiscation to Cooperation and Mobilization

    Abstract Full Text
    JAMA. 2014; 312(20):2099-2100. doi: 10.1001/jama.2014.15727

    This Editorial discusses 3 approaches to reshaping US health care.

  • Association Between Hospital Conversions to For-Profit Status and Clinical and Economic Outcomes

    Abstract Full Text
    free access has multimedia
    JAMA. 2014; 312(16):1644-1652. doi: 10.1001/jama.2014.13336

    This retrospective cohort study reports that hospital conversion to for-profit status was associated with improved financial margins but not with differences in quality or other measures.

  • Health Care Price Transparency and Economic Theory

    Abstract Full Text
    JAMA. 2014; 312(16):1642-1643. doi: 10.1001/jama.2014.14276
  • Who Benefits From Health System Change?

    Abstract Full Text
    JAMA. 2014; 312(16):1639-1641. doi: 10.1001/jama.2014.13491
  • From JAMA’s Daily News Site

    Abstract Full Text
    JAMA. 2014; 312(11):1087-1087. doi: 10.1001/jama.2014.12408
  • Effect of Providing Conditional Economic Compensation on Uptake of Voluntary Medical Male Circumcision in Kenya: A Randomized Clinical Trial

    Abstract Full Text
    free access
    JAMA. 2014; 312(7):703-711. doi: 10.1001/jama.2014.9087

    Thirumurthy and colleagues analyze whether the uptake of voluntary medical male circumcision increases with provision of compensation in a randomized clinical trial of 1502 uncircumcized men aged 25 to 49 years in Kenya.

  • “The Beautyful Ones Are Not Yet Born” Might Not Hold True For Much Longer : Njideka Akunyili

    Abstract Full Text
    JAMA. 2014; 312(7):680-681. doi: 10.1001/jama.2013.279671
  • JAMA August 6, 2014

    Figure: Excess Health Spending Growth in the United States and Other Industrialized Countries

    Periods when the US economy was in recession are shaded. Source: 2013 Organisation for Economic Co-operation and Development (OECD) health data. US health spending data are from National Health Expenditure Accounts, adjusted to meet OECD definitions (Centers for Medicare & Medicaid Services, Office of the Actuary, National Health Statistics Group).aThe OECD median includes only the 23 OECD countries with ≥25 years of data between 1980 and 2011.bIn 2012, data were available only for 12 OECD countries, including the United States.
  • JAMA June 25, 2014

    Figure: Economist: It’s Time for Tough Choices on US Health Costs

    Uwe Reinhardt, PhD, a professor of political economy at Princeton University in New Jersey, said the United States must have a civilized debate about difficult choices related to health spending.
  • Association Between Casino Opening or Expansion and Risk of Childhood Overweight and Obesity

    Abstract Full Text
    free access
    JAMA. 2014; 311(9):929-936. doi: 10.1001/jama.2014.604

    Jones-Smith and coauthors longitudinally assessed whether openings or expansions of American Indian–owned casinos were associated with childhood overweight/obesity risk in 117 school districts encompassing tribal lands in California. Halfon comments in an editorial.

  • New Drugs—Miracles or Mirages?

    Abstract Full Text
    JAMA. 2014; 311(4):423-423. doi: 10.1001/jama.2013.279299